OsteoGeneX
About OsteoGeneX
Developer of novel therapeutics to modulate the growth of bone and cancer. The company develops therapeutics based on the sclerostin (SOST) family and focused primarily on building new bone. [Keywords: bone morphogenetic proteins (BMPs), osteoporosis]
OsteoGeneX Headquarter Location
2002 West 39th Street
Kansas City, Kansas, 66160,
United States
(913)945-6763
OsteoGeneX Patents
OsteoGeneX has filed 4 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
6/30/2009 | 6/12/2012 | Rare diseases, Skeletal system, Clusters of differentiation, Orthopedic surgical procedures, Osteopathies | Grant |
Application Date | 6/30/2009 |
|---|---|
Grant Date | 6/12/2012 |
Title | |
Related Topics | Rare diseases, Skeletal system, Clusters of differentiation, Orthopedic surgical procedures, Osteopathies |
Status | Grant |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.